Welcome to our dedicated page for Longduoduo Co SEC filings (Ticker: LDDD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Longduoduo Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Longduoduo Co's regulatory disclosures and financial reporting.
Longduoduo Co Ltd (LDDD) reported that on September 14, 2026, three members of its Board of Directors — Binbin Wu, Jiayang Ma, and Bo Shan — resigned from the board. Each departing director stated that the decision to resign was not due to any disagreement regarding the company’s operations, policies, or procedures.
Longduoduo Company Limited reported a sharp downturn for the quarter and nine months ended March 31, 2026. Quarterly revenue dropped to $187,392, down 76% from $777,720 a year earlier, while net loss widened to $190,007. For the nine-month period, revenue fell to $1,191,421, a 64% decline from $3,322,287, swinging from net income of $325,775 to a net loss of $575,434. Most revenue came from commission income tied to a single customer, with healthcare service revenue remaining minimal. Operating expenses decreased, mainly from lower advertising spend, but not enough to offset the revenue shortfall. The company ended the period with cash of $1,224,881 and working capital of $502,587, relying heavily on customer prepayments and acknowledging uncertainty about generating sufficient cash flow and financing. Management also reported material weaknesses in disclosure controls and procedures.
Longduoduo Company Limited reported a sharp downturn for the quarter and six months ended December 31, 2025. Quarterly revenue fell to $345,265 from $1,775,495 a year earlier, and the company swung from net income of $501,599 to a net loss of $274,245.
For the six‑month period, revenue dropped to $1,004,029 from $2,544,567, with net results moving from a $442,095 profit to a $385,427 loss. Management attributes the decline mainly to a weaker economic environment in China that has made consumers more cautious about discretionary preventive healthcare spending.
Most revenue continues to come from commission income earned as sales agent for a single third‑party provider, creating heavy customer concentration. As of December 31, 2025, cash and cash equivalents were $1,543,479 and working capital was $634,590, while deferred revenue rose to $684,337 as the company used customer deposits to fund operations. Management also concluded that disclosure controls and procedures were not effective as of period end.
Longduoduo Company Limited (LDDD) filed its quarterly report for the three months ended September 30, 2025. Total revenue was $658,764, down 14% year over year, driven mainly by $653,158 of commission revenue from its sales‑agent model with Honghai and $5,606 of service revenue. Gross profit was $652,054, but selling, general and administrative expenses of $736,468 led to a loss from operations of $84,414. Net loss widened to $111,182.
Cash and cash equivalents were $1,247,296, and operating cash outflow was $374,184 as the company reduced accounts payable. Deferred revenue was $385,128, reflecting customer prepayments. One customer accounted for 99.1% of revenue, indicating high concentration. Management reported disclosure controls and procedures were not effective as of September 30, 2025. Shares outstanding were 30,015,036 as of the filing date.
Service volumes remained limited, producing a negative service gross margin as equipment depreciation outweighed revenue. The company continues to invest in advertising ($314,481) to build its brand while expanding leased offices across Inner Mongolia.
Longduoduo Co., Ltd. operates preventive healthcare services in China through a network of third-party providers and consolidated subsidiaries. The company reported positive net income of $492,260 for the year ended June 30, 2025, down from $1,363,278 a year earlier, and operating income declined from $2,026,141 to $552,679. Advertising and promotion expenses decreased to $1,942,661 from $3,338,737, and cash in excess of insured amounts was $1,130,547 at June 30, 2025. The company completed corporate reorganizations and acquisitions of multiple subsidiaries (including LDD, Julong, Yihua) and completed a 1-for-10 reverse stock split in September 2023, leaving 30,015,036 shares outstanding. Significant disclosures include a 100% valuation allowance on deferred tax assets and identified deficiencies in internal controls and accounting expertise.